Covered recipient · General Payments record
KIMBERLY JEAN SALENE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,225.71
- Reported across 188 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $581.65 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $316.83 | 15 |
| Novo Nordisk AS | $114.92 | 7 |
| Lilly USA, LLC | $68.13 | 4 |
| Acerta Pharma LLC | $40.09 | 2 |
| GlaxoSmithKline, LLC. | $21.80 | 1 |
| iRhythm Technologies, Inc. | $19.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.26 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005851 | CMS |
| ABBVIE INC. | $3.20 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005853 | CMS |
| ABBVIE INC. | $30.67 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005855 | CMS |
| ABBVIE INC. | $27.50 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005857 | CMS |
| ABBVIE INC. | $33.84 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005859 | CMS |
| ABBVIE INC. | $31.54 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005861 | CMS |
| ABBVIE INC. | $17.97 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005863 | CMS |
| ABBVIE INC. | $11.38 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005865 | CMS |
| ABBVIE INC. | $15.72 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005867 | CMS |
| ABBVIE INC. | $30.80 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005869 | CMS |
| ABBVIE INC. | $1.78 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005871 | CMS |
| ABBVIE INC. | $13.73 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005873 | CMS |
| ABBVIE INC. | $28.07 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005875 | CMS |
| ABBVIE INC. | $11.93 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005877 | CMS |
| ABBVIE INC. | $28.44 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106005879 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.93 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104696692 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.16 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105734187 | CMS |
| GlaxoSmithKline, LLC. | $21.80 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116286069 | CMS |
| iRhythm Technologies, Inc. | $19.88 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154057120 | CMS |
| Lilly USA, LLC | $16.51 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135136732 | CMS |
| Lilly USA, LLC | $17.26 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135107623 | CMS |
| Lilly USA, LLC | $16.27 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135124159 | CMS |
| Lilly USA, LLC | $18.09 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135124161 | CMS |
| Novo Nordisk Inc | $21.14 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097714806 | CMS |
| Novo Nordisk Inc | $18.04 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097740411 | CMS |
| Novo Nordisk Inc | $13.34 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096822097 | CMS |
| Novo Nordisk Inc | $13.72 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096595716 | CMS |
| Novo Nordisk Inc | $16.54 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097052344 | CMS |
| Novo Nordisk Inc | $17.39 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599281 | CMS |
| Novo Nordisk Inc | $14.75 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097634411 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.